endogenous glp 1 GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes GLP1 Receptor Agonists—Effects beyond Obesity

This review presented fundamental information regarding two categories of GLP-1 receptor agonists (GLP-1RAs): peptide-based and small molecule compounds, and elaborated their potential neuroprotective effects by inhibiting neuroinflammation, reducing neuronal apoptosis, and ultimately improving cognitive function in various neurodegenerative diseases

DiMarchi suspects that the GLP-1 might have reduced damaging inflammation in her brain from her postconcussion syndrome, which played a role in her turnaround

Ozempic and Mounjaro for type 2 diabetes and Wegovy and Zepbound for obesity)

The patients did not have conditions commonly associated with allodynia such as fibromyalgia , recent shingles, or diabetic neuropathy

Linagliptin is a drug that specifically acts upon the DPP-4 enzyme

If cardiovascular health is what you think is important for deciding between these drug classes, I think our most recent study provides some strong evidence